UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000030495
Receipt No. R000034813
Scientific Title An exploratory study to determine the genetic polymorphisms or mutations associated with type 1 diabetes and interstitial lung disease induced by immune checkpoint inhibitor; nivolumab
Date of disclosure of the study information 2017/12/21
Last modified on 2019/12/27 16:06:02

No. Disposal Last modified on Item of update
1 Insert 2017/12/20 19:04:36
2 Update 2018/07/04 18:38:26 Other related information
Other related information
3 Update 2018/07/04 18:40:21 Recruitment status
4 Update 2018/12/24 14:27:49 Organization
Co-sponsor
Co-sponsor
5 Update 2019/10/28 19:55:51 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Co-sponsor
Co-sponsor
Organization
Organization
Address
Address
Tel
Email
6 Update 2019/10/28 20:00:58 Date of IRB
Last follow-up date
7 Update 2019/12/27 15:55:48 Key inclusion criteria
Key inclusion criteria
Target sample size
8 Update 2019/12/27 16:00:14 Co-sponsor
9 Update 2019/12/27 16:05:08 Date analysis concluded
10 Update 2019/12/27 16:06:02 Date trial data considered complete


Contact us.